Continuous subcutaneous insulin infusion: practical issues
Open accessAbstract
The growing number of individuals with diabetes mellitus has prompted new way of treating these patients, continuous subcutaneous insulin infusion (CSII) or insulin pump therapy is an increasingly form of intensive insulin therapy. An increasing number of individuals with diabetes mellitus individuals of all ages have started using insulin pump therapy. Not everyone is a good candidate for insulin pump therapy, and the clinician needs to be able to determine which patients are able to master the techniques required and to watch for the adverse reactions that may develop. Insulin pump increases quality of life of patient with diabetes mellitus with increasing satisfaction with treatment and decrease impact of diabetes mellitus. Manual errors by insulin pump users may lead to hypo or hyperglycemia, resulting into diabetic ketoacidosis (DKA) sometimes. Some of practical aspect is associated with insulin pump therapy such as selection of candidates, handling of pump and selection of site, and pump setting, henceforth this review is prepared to explore and solve the practical problems or issues associated with pump therapy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Current occlusion alarm systems cannot detect other types of infusion failures such as leakages, dislodged cannulas, and silent occlusions.
“However, these detection thresholds are not standardized across manufacturers and cannot detect other types of infusion failures such as leakages, dislodged cannulas, and “silent” (ie, no alert) occlusions.15,16”
From Development of a Real-time Force-based Algorithm for Infusion Failure Detection (2024) · cites this paper as [16]
The Mechanical problems and Hyperglycemia sections identify leaks, displaced catheters, and blocked infusion sets as causes of unexplained high blood glucose; Mechanical problems also says leaks can be difficult to detect. Neither section says that occlusion alarms fail to detect these problems or silent occlusions, and the paper does not establish that alarm thresholds vary across manufacturers. No page numbers are available in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measuredOcclusion detection thresholds are not standardized across manufacturers.
“However, these detection thresholds are not standardized across manufacturers and cannot detect other types of infusion failures such as leakages, dislodged cannulas, and “silent” (ie, no alert) occlusions.15,16”
From Development of a Real-time Force-based Algorithm for Infusion Failure Detection (2024) · cites this paper as [16]
The Mechanical problems section discusses clogged infusion sets, leakage, and displaced sets, but does not address occlusion-detection thresholds or whether manufacturers standardize them. Searches for threshold standardization and occlusion-alarm pressure found no relevant passage in our copy; page numbers were not available. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works
(1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70190-3 · Cited by 1,654 · see citing works
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534 · see citing works
Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.
Pickup, J. C., KEEN, H., PARSONS, J. A., & Alberti, K. G. M. M. (1978) · BMJ · doi:10.1136/bmj.1.6107.204 · Cited by 563 · see citing works
Tamborlane, W. V., Sherwin, R. S., Genel, M., & Felig, P. (1979) · New England Journal of Medicine · doi:10.1056/nejm197903153001101 · Cited by 411 · see citing works
Continuous Subcutaneous Insulin Infusion at 25 Years
Pickup, J. C., & KEEN, H. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.593 · Cited by 397 · see citing works
Acute Complications Associated With Insulin Infusion Pump Therapy
Mecklenburg, R. S. (1984) · JAMA · doi:10.1001/jama.252.23.3265 · Cited by 184 · see citing works
Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus
Litton, J. C., Rice, A., Friedman, N. E., Oden, J., Lee, M., & Freemark, M. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.127500 · Cited by 166 · see citing works
Initiation and Management of Insulin Pump Therapy
Strowig, S. M. (1993) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572179301900110 · Cited by 13 · see citing works
Petrovski, G., Dimitrovski, Č., & Milenković, T. (2007) · PubMed · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- [7]Walsh J Roberts R Pumping insulin 2006 4th ed San Diego, CA Torrey Pines Press
- [8]The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N Engl J Med 1993 329 977 86 8366922
- [13]American Association of Diabetes Educators. Education for continuous subcutaneous insulin infusion pumps users Diabetes Educ 2003 29 97 9 12645494
- [16]Walsh J Roberts R Pumping insulin 2006 4th ed San Diego, CA Torrey Pines Press
Cited by
Sorted by citations
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review
Janež, A., Guja, C., Mitrakou, A., Lalic, N., Tankova, T., Czupryniak, L., Tabák, A. G., Prazny, M., Martinka, E., & Smircic-Duvnjak, L. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00743-7 · Cited by 177 · see citing works
Kalra, S., Tandon, N., Balhara, Y. P. S., Baruah, M., Chadha, M. D., Chandalia, H. B., KUMAR, K. M. P., Madhu, S., Mithal, A., Sahay, R. K., et al. (2017) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_97_17 · Cited by 60 · see citing works
Self-citationNath, A., Deb, D., Dey, R., & Das, S. (2018) · IET Systems Biology · doi:10.1049/iet-syb.2017.0093 · Cited by 54 · see citing works
Increasing the Lifetime of Insulin Cannula with Antifouling and Nitric Oxide Releasing Properties
Chug, M. K., Feit, C., & Brisbois, E. J. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00908 · Cited by 42 · see citing works
Islam, M. T., Hasan, M. W., Hassan, M. F., & Çeşmeci, Ş. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16070944 · Cited by 39 · see citing works
Severe Diabetic Ketoacidosis in Children with Type 1 Diabetes: Ongoing Challenges in Care
Randazzese, S. F., Rocca, M. L., Bombaci, B., Pisa, A. D., Giliberto, E., Inturri, T., Militi, D., Lombardo, F., Gitto, E., Salzano, G., et al. (2025) · Children · doi:10.3390/children12010110 · Cited by 27 · see citing works
Skin-Related Complications Among Adolescents With Type 1 Diabetes Using Insulin Pump Therapy
Hayek, A. A., Robert, A. A., & Dawish, M. A. A. (2018) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551418798794 · Cited by 27 · see citing works
Smartphone compatible nitric oxide releasing insert to prevent catheter-associated infections
Chug, M. K., & Brisbois, E. J. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.043 · Cited by 27 · see citing works
Children and young people with diabetes: recognition and management
Hamilton, H., Knudsen, G., Vaina, C. L., Smith, M. M., & Paul, S. P. (2017) · British Journal of Nursing · doi:10.12968/bjon.2017.26.6.340 · Cited by 26 · see citing works
Polsky, S., GIORDANO, D. A., Voelmle, M. K., Garcetti, R., & Garg, S. K. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1159910 · Cited by 16 · see citing works
Alvarenga, C. S., Banca, R. L. L., Neris, R. R., Sparapani, V. D. C., Fuentealba-Torres, M., Cartagena-Ramos, D., Leal, C. L., Esper, M., & Nascimento, L. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00950-7 · Cited by 15 · see citing works
Giessmann, L. C., & Kann, P. H. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0654-5134 · Cited by 15 · see citing works
An Antimicrobial and Antifibrotic Coating for Implantable Biosensors
Wareham‐Mathiassen, S., Jolly, P., Shanmugam, N. R., Jagannath, B., Prabhala, P., Zhai, Y., Özkan, A., Naziripour, A., Singh, R., Bengtsson, H. L., et al. (2025) · Biosensors · doi:10.3390/bios15030171 · Cited by 12 · see citing works
Automated Insulin Delivery—The Light at the End of the Tunnel
Turksoy, K., Frantz, N., Quinn, L., Dumin, M., Kilkus, J., Hibner, B., Çinar, A., & Littlejohn, E. (2017) · Jornal de Pediatria · doi:10.1016/j.jpeds.2017.02.055 · Cited by 8 · see citing works
Overview of novel routes of insulin: current status
ROY, L., & Bhattacharjee, M. (2020) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20204082 · Cited by 9 · see citing works
Yen, P. M., & Young, A. S. (2021) · Anesthesia Progress · doi:10.2344/anpr-68-03-16 · Cited by 7 · see citing works
Kurdi, S. M., Alamer, A., Wali, H., Badr, A. F., Pendergrass, M., Ahmed, N. J., Abraham, I. L., & Fazel, M. T. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.03.002 · Cited by 6 · see citing works
Ohueri, C. W., García, A. A., & Zuniga, J. A. (2021) · Qualitative Health Research · doi:10.1177/10497323211064231 · Cited by 4 · see citing works
Fagan, V. R. C., & Parsons, K. (2021) · Global Qualitative Nursing Research · doi:10.1177/2333393620981058 · Cited by 3 · see citing works
Dhayani, A., Bej, S., Mudnakudu-Nagaraju, K. K., Chakraborty, S., Srinath, P., Kumar, A. H., Ann Maria, P. S., Khristi, A., Ramakrishnan, S., & Vemula, P. K. (2022) · ChemNanoMat · doi:10.1002/cnma.202200184 · Cited by 3 · see citing works
Kesavadev, J., Jain, S. M., Muruganathan, A., & Das, A. K. (2014) · PubMed · Cited by 3 · see citing works
Development of a Real-time Force-based Algorithm for Infusion Failure Detection
Blanco, L. E., Wilcox, J. H., Hughes, M. S., & Lal, R. A. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241247530 · Cited by 2 · see citing works
Bakkar, A., Althobaiti, E., Alqahtani, I., Abualkhair, L. A., Kamal, N. M., Althobaiti, M., Alotaibi, T. N., Habib, L., Alharthi, L., Aljuaid, S. S., et al. (2025) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223251381573 · Cited by 2 · see citing works
Modelado y simulación de tecnologías para el tratamiento de la diabetes
Rosales, N. (2020) · doi:10.35537/10915/97299 · Cited by 2 · see citing works
Qualidade de vida e satisfação com o tratamento com bomba perfusora de Insulina
Sofia, A., Osório, R., & Cardoso, H. (2013)
Wardian, J. (2018) · Clinical Diabetes · doi:10.2337/cd18-0010
Prabhaharan, S., Shenoy, V. V., & Sangla, K. S. (2019) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v9i1.7294
RESALE OF REFURBISHED INSULIN PUMPS, IS IT POSSIBLE?
Gandhi, S. P., & Gandhi, S. (2022) · Indian Journal Of Applied Research · doi:10.36106/ijar/1400402
Warunyuwong, W., Boucsein, A., & Wheeler, B. J. (2025) · Diabetes Technology and Obesity Medicine · doi:10.1089/dtom.2025.0006
Automatic Glycemia Regulation of Type I Diabetes
MohammadRidha, T. (2017) · doi:10.70675/c8095ce6z5ef9z48edz90faz7d0b926f23a3
- Authors
- Saboo, B., & Talaviya, P.
- Affiliations
- Diabetes Care & Hormone Clinic (IN)
- Corresponding author
- Saboo, BanshiD
- Venue
- Indian Journal of Endocrinology and Metabolism
- Published
- 2012
- Volume
- 16
- Issue
- 8
- Pages
- 259
- ISSN
- 2230-8210 (ISSN-L)
- PMC
- PMC3603042
- OpenAlex
- W1481343876
- Cited by
- 32
- References
- 10
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 4 · 2016: 1 · 2014: 1 · 2013: 1
- FWCI
- 0.51
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- Indian Journal of Endocrinology and Metabolism (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Physical Sciences › Engineering › Biomedical Engineering › Intravenous Infusion Technology and Safety
- Keywords
- insulin pump therapy, diabetes mellitus, intensive insulin therapy, patient selection, hypoglycemia, hyperglycemia, diabetic ketoacidosis, quality of life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review